Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tocilizumab for Covid-19 — The Ongoing Search for Effective Therapies
Edmund Huang, Stanley C. Jordan
New England Journal of Medicine (2020) Vol. 383, Iss. 24, pp. 2387-2388
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

COVID-19 and the human innate immune system
Joachim L. Schultze, Anna C. Aschenbrenner
Cell (2021) Vol. 184, Iss. 7, pp. 1671-1692
Open Access | Times Cited: 661
Nonsteroidal Anti-inflammatory Drugs Dampen the Cytokine and Antibody Response to SARS-CoV-2 Infection
Jennifer Chen, Mia Madel Alfajaro, Ryan D. Chow, et al.
Journal of Virology (2021) Vol. 95, Iss. 7
Open Access | Times Cited: 135
Single-cell immunology of SARS-CoV-2 infection
Yuan Tian, Lindsay N. Carpp, Helen E. R. Miller, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 1, pp. 30-41
Open Access | Times Cited: 100
Haemophagocytic syndrome and COVID-19
Soledad Retamozo, Pilar Brito‐Zerón, Antoni Sisó‐Almirall, et al.
Clinical Rheumatology (2021) Vol. 40, Iss. 4, pp. 1233-1244
Open Access | Times Cited: 82
Navigating the Uncertainties of COVID-19–Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis
Frédéric Lamoth, Russell E. Lewis, Thomas J. Walsh, et al.
The Journal of Infectious Diseases (2021)
Open Access | Times Cited: 60
Tocilizumab and COVID-19: Timing of Administration and Efficacy
Emna Abidi, Wasim S. El Nekidy, Eman Alefishat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 41
Could the fibromyalgia syndrome be triggered or enhanced by COVID-19?
Maria Fernanda Pessano Fialho, Evelyne da Silva Brum, Sara Marchesan Oliveira
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 633-651
Open Access | Times Cited: 25
Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells
Ji Youn Youn, Yixuan Zhang, Yusi Wu, et al.
Redox Biology (2021) Vol. 46, pp. 102099-102099
Open Access | Times Cited: 53
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, et al.
Seminars in Immunology (2021) Vol. 55, pp. 101508-101508
Open Access | Times Cited: 53
Comparison of effectiveness and safety between baricitinib and tocilizumab in severe COVID-19. A retrospective study
Ioannis Tomos, Ioannis Grigoropoulos, Chrysavgi Kosti, et al.
Expert Review of Respiratory Medicine (2025), pp. 1-9
Closed Access
Effector CD8 T cell differentiation in primary and breakthrough SARS-CoV-2 infection in mice
Brock Kingstad-Bakke, Woojong Lee, Boyd L. Yount, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients
Varun K. Phadke, Nicholas Scanlon, Stanley C. Jordan, et al.
Current Transplantation Reports (2021) Vol. 8, Iss. 2, pp. 127-139
Open Access | Times Cited: 37
A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling
Djo Hasan, Atsuko Shono, C.K. van Kalken, et al.
Purinergic Signalling (2021) Vol. 18, Iss. 1, pp. 13-59
Open Access | Times Cited: 30
Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India
Yojana Gokhale, Rakshita Mehta, Uday Kulkarni, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 29
COVID‐19 cooling: Nanostrategies targeting cytokine storm for controlling severe and critical symptoms
Yu Zheng, Yuke Li, Li Mao, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 738-811
Closed Access | Times Cited: 8
An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry
Daniel J. Weiss, Anthony J. Filiano, Jacques Galipeau, et al.
Cytotherapy (2022) Vol. 24, Iss. 11, pp. 1071-1073
Open Access | Times Cited: 10
Case Report: Takotsubo Syndrome Associated With Novel Coronavirus Disease 2019
Sofia Ortuno, Mathieu Jozwiak, Jean‐Paul Mira, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 13
Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients
Tomonori Kaneko, Sally Ezra, Rober Abdo, et al.
Clinical Proteomics (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?
Alexia Plocque, Christie Mitri, Charlène Lefèvre, et al.
Drugs (2022) Vol. 83, Iss. 1, pp. 1-36
Open Access | Times Cited: 8
Lung Ultrasound in Patients With SARS‐COV ‐2 Pneumonia: Correlations With Chest Computed Tomography, Respiratory Impairment, and Inflammatory Cascade
Gerardina Fratianni, Gabriella Malfatto, Elisa Perger, et al.
Journal of Ultrasound in Medicine (2021) Vol. 41, Iss. 6, pp. 1465-1473
Open Access | Times Cited: 9
A Phase 1a/1b Clinical Trial Design to Assess Safety, Acceptability, Pharmacokinetics and Tolerability of Intranasal Q-Griffithsin for COVID-19 Prophylaxis
Henry W. Nabeta, Maryam Zahin, Joshua L. Fuqua, et al.
The University of Louisville Journal of Respiratory Infections (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 6
Response to: ‘Correspondence on ‘Preliminary predictive criteria for COVID-19 cytokine storm’’ by Tampe et al
Roberto Caricchio, Marcello Gallucci, Chandra Dass, et al.
Annals of the Rheumatic Diseases (2021) Vol. 82, Iss. 3, pp. e72-e72
Open Access | Times Cited: 8
3D genomic capture of regulatory immuno-genetic profiles in COVID-19 patients for prognosis of severe COVID disease outcome
Ewan Hunter, Christina Koutsothanasi, Adam J. Wilson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 7
Treatment strategies of COVID-19: A rheumatology perspective
Alexandros A. Drosos, Eleftherios Pelechas, Paraskevi V. Voulgari
European Journal of Internal Medicine (2022) Vol. 102, pp. 17-23
Open Access | Times Cited: 5
Predicting factors associated with prolonged intensive care unit stay of patients with COVID-19
Won Ho Han, Jae Hoon Lee, June Young Chun, et al.
Acute and Critical Care (2023) Vol. 38, Iss. 1, pp. 41-48
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top